Georgina M. Kerr

Old Road Campus Research Building, Roosevelt Drive
Oxford, ENG OX37DQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Justifying quarantine in preventing the spread of COVID-19 in healthcare.

Justifying quarantine in preventing the spread of COVID-19 in healthcare.

Journal: Occupational medicine (Oxford, England)

Published: August 29, 2021

ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex.

ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex.

Journal: Biomedicines

Published: December 31, 2020

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.

Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.

Journal: bioRxiv : the preprint server for biology

Published: June 25, 2020

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

Journal: Nature immunology

Published: June 02, 2020

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.

Journal: JBMR plus

Published: June 18, 2019

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva.

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva.

Journal: JCI insight

Published: May 09, 2017

A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.

A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis.

Journal: Angiogenesis

Published: August 20, 2014

A new class of small molecule inhibitor of BMP signaling.

A new class of small molecule inhibitor of BMP signaling.

Journal: PloS one

Published: December 30, 2012

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.

Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva.

Journal: The Journal of biological chemistry

Published: September 15, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026